Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

YIELD10 BIOSCIENCE, INC.

(YTEN)
  Report
Delayed Nasdaq  -  04:00:01 2023-01-30 pm EST
3.900 USD   +6.56%
01/24Yield10 Bioscience, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
01/12Sector Update: Energy Stocks Finish Slightly Below Intra-Day Highs
MT
01/12Sector Update: Energy
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/24/2023 01/25/2023 01/26/2023 01/27/2023 01/30/2023 Date
3.35(c) 3.61(c) 4.1(c) 3.66(c) 3.9(c) Last
101 660 132 112 170 084 86 626 41 910 Volume
+8.06% +7.76% +13.57% -10.73% +6.56% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 0,49 M - -
Net income 2022 -13,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,46x
Yield 2022 -
Sales 2023 4,31 M - -
Net income 2023 -14,3 M - -
Net Debt 2023 - - -
P/E ratio 2023 -1,94x
Yield 2023 -
Capitalization 19,4 M 19,4 M -
Capi. / Sales 2022 39,7x
Capi. / Sales 2023 4,49x
Nbr of Employees 29
Free-Float 80,9%
More Financials
Company
Yield10 Bioscience, Inc. is an agricultural bioscience company. The Company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low-carbon sustainable seed products. The Company focuses on petroleum replacement markets, in which it is developing Camelina oil for use as a biofuel feedstock and polyhydroxyalkanoates (PHA) bioplastics produced in Camelina seed for use... 
More about the company
Ratings of Yield10 Bioscience, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about YIELD10 BIOSCIENCE, INC.
01/24Yield10 Bioscience, Inc. : Entry into a Material Definitive Agreement, Financial Statement..
AQ
01/12Sector Update: Energy Stocks Finish Slightly Below Intra-Day Highs
MT
01/12Sector Update: Energy
MT
01/12Top Midday Gainers
MT
01/12Yield10 Bioscience Signs MOU With Mitsubishi for Biofuel Partnership; Shares Jump Thurs..
MT
01/12Slowing US Inflation Buoys US Equity Futures
MT
01/12Top Premarket Gainers
MT
01/12North American Morning Briefing: Stock Futures Steady Ahead of CPI
DJ
01/11Stocks to Watch: Disney, Yield10 Bioscience, KB Home
DJ
01/11Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of..
AQ
01/11Yield10 Bioscience, Inc. and Mitsubishi Corporation Signs MOU to Evaluate the Establish..
CI
2022Yield10 Bioscience to Present at the CG AgriFoodáTech Innovation Virtual Forum
AQ
2022Transcript : Yield10 Bioscience, Inc., Q3 2022 Earnings Call, Nov 14, 2022
CI
2022YIELD10 BIOSCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2022Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months..
CI
More news
News in other languages on YIELD10 BIOSCIENCE, INC.
01/12Mise à jour sectorielle : Les actions du secteur de l'énergie te..
01/12Mise à jour sectorielle : Énergie
01/12Principaux gagnants de la mi-journée
01/12Yield10 Bioscience signe un protocole d'entente avec Mitsubishi pour un partenariat dan..
01/12Le ralentissement de l'inflation américaine stimule les contrats à terme sur actions am..
More news
Analyst Recommendations on YIELD10 BIOSCIENCE, INC.
More recommendations
Chart YIELD10 BIOSCIENCE, INC.
Duration : Period :
Yield10 Bioscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YIELD10 BIOSCIENCE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 3,90 $
Average target price 14,67 $
Spread / Average Target 276%
EPS Revisions
Managers and Directors
Oliver P. Peoples President, Chief Executive Officer & Director
Charles B. Haaser Chief Accounting Officer, Treasurer & VP-Finance
Robert L. van Nostrand Chairman
Kristi D. Snell Chief Science Officer & Vice President-Research
Anthony J. Sinskey Independent Director
Sector and Competitors
1st jan.Capi. (M$)
YIELD10 BIOSCIENCE, INC.133.60%19
MODERNA, INC.5.42%72 745
LONZA GROUP AG17.24%42 787
IQVIA HOLDINGS INC.12.00%42 622
ALNYLAM PHARMACEUTICALS, INC.-2.64%28 465
SEAGEN INC.8.93%26 117